peptide,lca,superkingdom,kingdom,subkingdom,superphylum,phylum,subphylum,superclass,class,subclass,infraclass,superorder,order,suborder,infraorder,parvorder,superfamily,family,subfamily,tribe,subtribe,genus,subgenus,species group,species subgroup,species,subspecies,varietas,forma,EC,EC - names,GO (cellular component),GO (molecular function),GO (biological process),GO (cellular component) - names,GO (molecular function) - names,GO (biological process) - names,InterPro,InterPro - names
LSSPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (11%);GO:0016021 (2%),extracellular space (11%);integral component of membrane (2%),GO:0004252 (100%);GO:0046872 (4%),serine-type endopeptidase activity (100%);metal ion binding (4%),GO:0006508 (11%);GO:0007586 (4%),proteolysis (11%);digestion (4%),IPR001254 (100%);IPR009003 (100%);IPR043504 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1, PA clan, chymotrypsin-like fold (100%)
LSSPATLDSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VATVSPLR,Solirubrobacteraceae,Bacteria,,,,Actinobacteria,,,Thermoleophilia,,,Solirubrobacterales,,,,Solirubrobacteraceae,,,,,,,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),,,,,IPR003838 (100%);IPR025857 (100%),ABC3 transporter permease protein domain (100%);MacB-like periplasmic core domain (100%)
TVMVEVTK,Sphingomonadaceae,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,Sphingomonadales,,,,Sphingomonadaceae,,,,,,,,,,,,,,,,GO:0009279 (100%),cell outer membrane (100%),,,,,IPR000531 (100%);IPR012910 (100%);IPR036942 (100%),TonB-dependent receptor-like, beta-barrel (100%);TonB-dependent receptor, plug domain (100%);TonB-dependent receptor-like, beta-barrel domain superfamily (100%)
VVTVLSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007165 (100%),signal transduction (100%),IPR000157 (100%);IPR035897 (100%),Toll/interleukin-1 receptor homology (TIR) domain (100%);Toll/interleukin-1 receptor homology (TIR) domain superfamily (100%)
ELYLSWVVEAR,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,1.6.2.4 (100%),NADPH--hemoprotein reductase (100%),GO:0016021 (90%);GO:0005789 (76%);GO:0005783 (8%),integral component of membrane (90%);endoplasmic reticulum membrane (76%);endoplasmic reticulum (8%),GO:0010181 (95%);GO:0003958 (88%);GO:0050660 (76%),FMN binding (95%);NADPH-hemoprotein reductase activity (88%);flavin adenine dinucleotide binding (76%),GO:0009725 (5%);GO:0003420 (2%);GO:0007584 (2%),response to hormone (5%);regulation of growth plate cartilage chondrocyte proliferation (2%);response to nutrient (2%),IPR003097 (100%);IPR017938 (100%);IPR023173 (100%),Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding (100%);Riboflavin synthase-like beta-barrel (100%);NADPH-cytochrome p450 reductase, FAD-binding, alpha-helical domain superfamily (100%)
QEFLNAAK,Phorcysia thermohydrogeniphila,Bacteria,,,,Aquificae,,,Aquificae,,,Desulfurobacteriales,,,,Desulfurobacteriaceae,,,,Phorcysia,,,,Phorcysia thermohydrogeniphila,,,,,,,,,,GO:0009055 (100%);GO:0020037 (100%);GO:0046872 (100%),electron transfer activity (100%);heme binding (100%);metal ion binding (100%),,,IPR009056 (100%),Cytochrome c-like domain (100%)
LATVLSPR,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR002634 (100%);IPR036065 (100%),BolA protein (100%);BolA-like superfamily (100%)
NWQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YYTLEELQK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (74%);GO:0005783 (29%);GO:0005829 (18%),integral component of membrane (74%);endoplasmic reticulum (29%);cytosol (18%),GO:0020037 (97%);GO:0046872 (97%);GO:0019899 (18%),heme binding (97%);metal ion binding (97%);enzyme binding (18%),GO:0046686 (3%);GO:0006631 (1%);GO:0019852 (1%),response to cadmium ion (3%);fatty acid metabolic process (1%);L-ascorbic acid metabolic process (1%),IPR001199 (100%);IPR036400 (100%);IPR018506 (95%),Cytochrome b5-like heme/steroid binding domain (100%);Cytochrome b5-like heme/steroid binding domain superfamily (100%);Cytochrome b5, heme-binding site (95%)
SLVNLGGSK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0005886 (61%);GO:0001533 (33%),keratin filament (100%);plasma membrane (61%);cornified envelope (33%),GO:0046982 (35%);GO:0030246 (33%);GO:0030280 (33%),protein heterodimerization activity (35%);carbohydrate binding (33%);structural constituent of skin epidermis (33%),GO:0051290 (35%);GO:0001867 (33%);GO:0018149 (33%),protein heterotetramerization (35%);complement activation, lectin pathway (33%);peptide cross-linking (33%),IPR003054 (100%);IPR032444 (100%);IPR039008 (100%),Keratin, type II (100%);Keratin type II head (100%);Intermediate filament, rod domain (100%)
SPATLSNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVDLAAVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLAAMMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003677 (50%),DNA binding (50%),GO:0000160 (50%);GO:0006355 (50%),phosphorelay signal transduction system (50%);regulation of transcription, DNA-templated (50%),IPR001789 (50%);IPR001867 (50%);IPR011006 (50%),Signal transduction response regulator, receiver domain (50%);OmpR/PhoB-type DNA-binding domain (50%);CheY-like superfamily (50%)
SSPATLNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLEGNEQFLNAAK,Simiiformes,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (15%);GO:0005576 (4%);GO:1904724 (4%),extracellular space (15%);extracellular region (4%);tertiary granule lumen (4%),GO:0004252 (100%);GO:0005509 (12%);GO:0008236 (4%),serine-type endopeptidase activity (100%);calcium ion binding (12%);serine-type peptidase activity (4%),GO:0006508 (12%);GO:0031638 (12%);GO:0043542 (12%),proteolysis (12%);zymogen activation (12%);endothelial cell migration (12%),IPR001254 (100%);IPR009003 (100%);IPR043504 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1, PA clan, chymotrypsin-like fold (100%)
YLYEALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.3.19 (33%);3.5.2.6 (33%);3.5.4.4 (33%),4-methylaminobutanoate oxidase (formaldehyde-forming) (33%);Beta-lactamase (33%);Adenosine deaminase (33%),GO:0016021 (7%);GO:0005886 (4%);GO:0031514 (4%),integral component of membrane (7%);plasma membrane (4%);motile cilium (4%),GO:0016491 (37%);GO:0001681 (11%);GO:0004197 (9%),oxidoreductase activity (37%);sialate O-acetylesterase activity (11%);cysteine-type endopeptidase activity (9%),GO:0006979 (2%);GO:0019350 (2%);GO:0031119 (2%),response to oxidative stress (2%);teichoic acid biosynthetic process (2%);tRNA pseudouridine synthesis (2%),IPR002347 (30%);IPR020904 (30%);IPR036291 (30%),Short-chain dehydrogenase/reductase SDR (30%);Short-chain dehydrogenase/reductase, conserved site (30%);NAD(P)-binding domain superfamily (30%)
MVLNAAPHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSQSAGTECLLSGWGAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MSSSSGYLMEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPATLNNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPGVSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMFPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHFPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLSLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.2 (24%);2.7.10.2 (14%);2.7.13.3 (9%),Methylmalonyl-CoA mutase (24%);Non-specific protein-tyrosine kinase (14%);Histidine kinase (9%),GO:0016021 (31%);GO:0005886 (7%);GO:0005737 (6%),integral component of membrane (31%);plasma membrane (7%);cytoplasm (6%),GO:0005524 (18%);GO:0046872 (16%);GO:0004494 (10%),ATP binding (18%);metal ion binding (16%);methylmalonyl-CoA mutase activity (10%),GO:0007165 (2%);GO:0006351 (2%);GO:0005975 (2%),signal transduction (2%);transcription, DNA-templated (2%);carbohydrate metabolic process (2%),IPR027417 (10%);IPR016176 (9%);IPR006099 (9%),P-loop containing nucleoside triphosphate hydrolase (10%);Cobalamin (vitamin B12)-dependent enzyme, catalytic (9%);Methylmalonyl-CoA mutase, alpha/beta chain, catalytic (9%)
NQYLSWLLTAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
STSSFSLCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLGFSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (40%);5.6.2.1 (40%);3.6.4.12 (20%),RNA-directed RNA polymerase (40%);DNA topoisomerase (40%);DNA helicase (20%),,,GO:0003677 (44%);GO:0000155 (33%);GO:0000287 (22%),DNA binding (44%);phosphorelay sensor kinase activity (33%);magnesium ion binding (22%),GO:0006265 (22%);GO:0039694 (22%);GO:0006139 (11%),DNA topological change (22%);viral RNA genome replication (22%);nucleobase-containing compound metabolic process (11%),IPR000253 (33%);IPR003018 (33%);IPR003594 (33%),Forkhead-associated (FHA) domain (33%);GAF domain (33%);Histidine kinase/HSP90-like ATPase (33%)
SSPATTSGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLHPGPSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHMLHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VATVSTMHTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMLMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLGAYK,Eubacteriales,Bacteria,,,,Firmicutes,,,Clostridia,,,Eubacteriales,,,,,,,,,,,,,,,,,,5.3.1.9 (100%),Glucose-6-phosphate isomerase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0004347 (100%),glucose-6-phosphate isomerase activity (100%),GO:0006094 (100%);GO:0006096 (100%),gluconeogenesis (100%);glycolytic process (100%),IPR010551 (100%);IPR011051 (100%);IPR014710 (100%),Glucose-6-phosphate isomerase, prokaryote (100%);RmlC-like cupin domain superfamily (100%);RmlC-like jelly roll fold (100%)
DLFAPNK,Mycosphaerellales,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Dothideomycetes,Dothideomycetidae,,Mycosphaerellales,,,,,,,,,,,,,,,,,,,,,,,,,,IPR018961 (100%),DnaJ homologue, subfamily C, member 28, conserved domain (100%)
APVLFGGDCK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELYLSWTTPVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WHMSFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYDLVTVWLVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CMGDDAAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGWLTSEMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLHSPPGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLSYGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLLDNAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.107 (21%);3.1.-.- (16%);4.1.1.23 (16%),Uroporphyrinogen-III C-methyltransferase (21%);Acting on ester bonds (16%);Orotidine-5'-phosphate decarboxylase (16%),GO:0016021 (13%);GO:0005737 (8%);GO:0005634 (3%),integral component of membrane (13%);cytoplasm (8%);nucleus (3%),GO:0003677 (16%);GO:0005524 (14%);GO:0003746 (11%),DNA binding (16%);ATP binding (14%);translation elongation factor activity (11%),GO:0032784 (11%);GO:0009306 (6%);GO:0032259 (6%),regulation of DNA-templated transcription, elongation (11%);protein secretion (6%);methylation (6%),IPR000308 (13%);IPR023409 (13%);IPR023410 (13%),14-3-3 protein (13%);14-3-3 protein, conserved site (13%);14-3-3 domain (13%)
DHHDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.9 (70%);2.7.7.48 (5%);3.4.22.28 (5%),Glucose-6-phosphate isomerase (70%);RNA-directed RNA polymerase (5%);Picornain 3C (5%),GO:0005737 (16%);GO:0016021 (14%);GO:0005634 (4%),cytoplasm (16%);integral component of membrane (14%);nucleus (4%),GO:0046872 (33%);GO:0051536 (29%);GO:0003824 (22%),metal ion binding (33%);iron-sulfur cluster binding (29%);catalytic activity (22%),GO:0006094 (15%);GO:0006096 (15%);GO:0010088 (4%),gluconeogenesis (15%);glycolytic process (15%);phloem development (4%),IPR007197 (26%);IPR013785 (26%);IPR017833 (26%),Radical SAM (26%);Aldolase-type TIM barrel (26%);Hopanoid biosynthesis associated radical SAM protein HpnH (26%)
HMLMHLFDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLLSSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7.1.7 (51%);5.6.2.2 (17%);2.4.1.- (7%),GMP reductase (51%);DNA topoisomerase (ATP-hydrolyzing) (17%);Hexosyltransferases (7%),GO:0016021 (36%);GO:1902560 (14%);GO:0005737 (8%),integral component of membrane (36%);GMP reductase complex (14%);cytoplasm (8%),GO:0005524 (19%);GO:0003920 (14%);GO:0046872 (10%),ATP binding (19%);GMP reductase activity (14%);metal ion binding (10%),GO:0006163 (14%);GO:0006265 (5%);GO:0006464 (5%),purine nucleotide metabolic process (14%);DNA topological change (5%);cellular protein modification process (5%),IPR000210 (28%);IPR011333 (28%);IPR043225 (20%),BTB/POZ domain (28%);SKP1/BTB/POZ domain superfamily (28%);BTBD8, BACK domain (20%)
WNLVHLFDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLTHPCSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMVWLHVLDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLYVHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLLHGGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.7 (86%);2.1.2.3 (14%);3.5.4.10 (14%),UDP-N-acetylglucosamine 1-carboxyvinyltransferase (86%);Phosphoribosylaminoimidazolecarboxamide formyltransferase (14%);IMP cyclohydrolase (14%),GO:0005737 (63%);GO:0009380 (25%);GO:0015935 (6%),cytoplasm (63%);excinuclease repair complex (25%);small ribosomal subunit (6%),GO:0008760 (50%);GO:0003677 (25%);GO:0004518 (25%),UDP-N-acetylglucosamine 1-carboxyvinyltransferase activity (50%);DNA binding (25%);nuclease activity (25%),GO:0007049 (50%);GO:0008360 (50%);GO:0009252 (50%),cell cycle (50%);regulation of cell shape (50%);peptidoglycan biosynthetic process (50%),IPR001986 (47%);IPR005750 (47%);IPR013792 (47%),Enolpyruvate transferase domain (47%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (47%);RNA 3'-terminal phosphate cyclase/enolpyruvate transferase, alpha/beta (47%)
QLPSAADPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTVHPGHK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLMPKPPNVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CDYNATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYYHLTASK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVTVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (100%);GO:0008134 (100%);GO:0043565 (100%),ATP binding (100%);transcription factor binding (100%);sequence-specific DNA binding (100%),GO:0000160 (100%);GO:0006355 (100%),phosphorelay signal transduction system (100%);regulation of transcription, DNA-templated (100%),IPR001789 (100%);IPR002078 (100%);IPR002197 (100%),Signal transduction response regulator, receiver domain (100%);RNA polymerase sigma factor 54 interaction domain (100%);DNA binding HTH domain,  Fis-type (100%)
VLQGNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSLSVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.3.1 (75%);2.7.9.2 (25%),Sarcosine oxidase (75%);Pyruvate, water dikinase (25%),GO:0005737 (60%);GO:0031463 (20%),cytoplasm (60%);Cul3-RING ubiquitin ligase complex (20%),GO:0008115 (60%);GO:0005524 (20%);GO:0008986 (20%),sarcosine oxidase activity (60%);ATP binding (20%);pyruvate, water dikinase activity (20%),GO:0046653 (60%);GO:0006090 (20%);GO:0006094 (20%),tetrahydrofolate metabolic process (60%);pyruvate metabolic process (20%);gluconeogenesis (20%),IPR006222 (50%);IPR006277 (50%);IPR013977 (50%),Aminomethyltransferase, folate-binding domain (50%);Sarcosine oxidase, alpha subunit (50%);Glycine cleavage T-protein, C-terminal barrel domain (50%)
DMLQYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.4 (57%);2.1.1.72 (14%);2.7.10.2 (14%),Tripeptide aminopeptidase (57%);Site-specific DNA-methyltransferase (adenine-specific) (14%);Non-specific protein-tyrosine kinase (14%),GO:0016021 (16%);GO:0005737 (13%);GO:0005886 (6%),integral component of membrane (16%);cytoplasm (13%);plasma membrane (6%),GO:0008168 (35%);GO:0008237 (13%);GO:0008270 (13%),methyltransferase activity (35%);metallopeptidase activity (13%);zinc ion binding (13%),GO:0032259 (35%);GO:0043171 (13%);GO:0006310 (6%),methylation (35%);peptide catabolic process (13%);DNA recombination (6%),IPR001261 (18%);IPR002933 (18%);IPR010161 (18%),ArgE/DapE/ACY1/CPG2/YscS, conserved site (18%);Peptidase M20 (18%);Peptidase M20B, tripeptide aminopeptidase (18%)
MVLDAWFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLDAAVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSGWSGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.58 (100%),RNA 2',3'-cyclic 3'-phosphodiesterase (100%),GO:0016021 (25%),integral component of membrane (25%),GO:0004113 (25%);GO:0008664 (25%);GO:0016787 (25%),2',3'-cyclic-nucleotide 3'-phosphodiesterase activity (25%);2'-5'-RNA ligase activity (25%);hydrolase activity (25%),GO:0005975 (25%),carbohydrate metabolic process (25%),IPR011055 (50%);IPR016047 (50%);IPR002509 (13%),Duplicated hybrid motif (50%);Peptidase M23 (50%);NodB homology domain (13%)
SPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004252 (100%),serine-type endopeptidase activity (100%),,,IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
NVSGHGYTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGPVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0051301 (80%),cell division (80%),IPR001182 (100%),Probable peptidoglycan glycosyltransferase FtsW/RodA (100%)
EMVNLAAVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPGVVTPR,Amphimedon queenslandica,Eukaryota,Metazoa,,,Porifera,,,Demospongiae,Heteroscleromorpha,,Haplosclerida,,,,Niphatidae,,,,Amphimedon,,,,Amphimedon queenslandica,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0007155 (50%);GO:0007229 (50%),cell adhesion (50%);integrin-mediated signaling pathway (50%),IPR014836 (100%);IPR015812 (100%);IPR002369 (50%),Integrin beta subunit, cytoplasmic domain (100%);Integrin beta subunit (100%);Integrin beta subunit, VWA domain (50%)
MHMPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYNMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (9%);3.5.1.- (7%);5.4.99.12 (7%),Peptidylprolyl isomerase (9%);In linear amides (7%);tRNA pseudouridine(38-40) synthase (7%),GO:0016021 (18%);GO:0005576 (10%);GO:0019028 (5%),integral component of membrane (18%);extracellular region (10%);viral capsid (5%),GO:0016491 (15%);GO:0016810 (13%);GO:0046872 (9%),oxidoreductase activity (15%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (13%);metal ion binding (9%),GO:0005975 (16%);GO:0007420 (10%);GO:0035082 (10%),carbohydrate metabolic process (16%);brain development (10%);axoneme assembly (10%),IPR027968 (23%);IPR036291 (12%);IPR000683 (10%),Jhy protein (23%);NAD(P)-binding domain superfamily (12%);Gfo/Idh/MocA-like oxidoreductase, N-terminal (10%)
SSPATSGPTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APVLDSCSSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WVCYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.4 (100%),Phospholipase D (100%),GO:0016021 (24%);GO:0030131 (8%);GO:0005669 (3%),integral component of membrane (24%);clathrin adaptor complex (8%);transcription factor TFIID complex (3%),GO:0008080 (22%);GO:0004630 (14%);GO:0035091 (14%),N-acetyltransferase activity (22%);phospholipase D activity (14%);phosphatidylinositol binding (14%),GO:0015031 (14%);GO:0016042 (14%);GO:0006654 (11%),protein transport (14%);lipid catabolic process (14%);phosphatidic acid biosynthetic process (11%),IPR000182 (16%);IPR016181 (16%);IPR011051 (14%),GNAT domain (16%);Acyl-CoA N-acyltransferase (16%);RmlC-like cupin domain superfamily (14%)
HMMPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.75 (25%);3.2.1.14 (25%);2.1.1.- (13%),tRNA dimethylallyltransferase (25%);Chitinase (25%);Methyltransferases (13%),GO:0016021 (16%);GO:0030015 (13%);GO:0005739 (7%),integral component of membrane (16%);CCR4-NOT core complex (13%);mitochondrion (7%),GO:0003677 (21%);GO:0005524 (18%);GO:0016887 (8%),DNA binding (21%);ATP binding (18%);ATPase (8%),GO:0006355 (13%);GO:0006417 (13%);GO:0051492 (9%),regulation of transcription, DNA-templated (13%);regulation of translation (13%);regulation of stress fiber assembly (9%),IPR027417 (13%);IPR000792 (12%);IPR007196 (12%),P-loop containing nucleoside triphosphate hydrolase (13%);Transcription regulator LuxR, C-terminal (12%);CCR4-Not complex component, Not1, C-terminal (12%)
HFPMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMLMHLTTGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVNELVMAMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YSMMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QPMHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MCGDDAAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNMTQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.14 (64%);2.7.7.6 (14%);1.8.4.11 (7%),Glycine--tRNA ligase (64%);DNA-directed RNA polymerase (14%);Peptide-methionine (S)-S-oxide reductase (7%),GO:0005737 (41%);GO:0016021 (7%);GO:0000502 (4%),cytoplasm (41%);integral component of membrane (7%);proteasome complex (4%),GO:0003677 (41%);GO:0005524 (37%);GO:0004820 (33%),DNA binding (41%);ATP binding (37%);glycine-tRNA ligase activity (33%),GO:0006426 (33%);GO:0006351 (7%);GO:0009405 (7%),glycyl-tRNA aminoacylation (33%);transcription, DNA-templated (7%);obsolete pathogenesis (7%),IPR002315 (33%);IPR004154 (33%);IPR006195 (33%),Glycyl-tRNA synthetase (33%);Anticodon-binding (33%);Aminoacyl-tRNA synthetase, class II (33%)
MHPMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WMVNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.9 (45%);4.2.1.22 (17%);6.2.-.- (9%),Valine--tRNA ligase (45%);Cystathionine beta-synthase (17%);Forming carbon-sulfur bonds (9%),GO:0005737 (33%);GO:0016021 (20%);GO:0005768 (5%),cytoplasm (33%);integral component of membrane (20%);endosome (5%),GO:0005524 (25%);GO:0002161 (21%);GO:0004832 (21%),ATP binding (25%);aminoacyl-tRNA editing activity (21%);valine-tRNA ligase activity (21%),GO:0006438 (20%);GO:0006535 (8%);GO:0019343 (8%),valyl-tRNA aminoacylation (20%);cysteine biosynthetic process from serine (8%);cysteine biosynthetic process via cystathionine (8%),IPR007493 (33%);IPR036758 (33%);IPR002300 (12%),Protein of unknown function DUF538 (33%);At5g01610-like superfamily (33%);Aminoacyl-tRNA synthetase, class Ia (12%)
WYYHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVTVSLPR,Actinobacteria,Bacteria,,,,Actinobacteria,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (100%);GO:0005886 (33%),integral component of membrane (100%);plasma membrane (33%),GO:0000155 (33%),phosphorelay sensor kinase activity (33%),,,IPR003594 (33%);IPR003660 (33%);IPR003661 (33%),Histidine kinase/HSP90-like ATPase (33%);HAMP domain (33%);Signal transduction histidine kinase, dimerisation/phosphoacceptor domain (33%)
VVHLGFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TMQTQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (60%);GO:0016021 (20%),nucleus (60%);integral component of membrane (20%),GO:0003677 (10%);GO:0005524 (10%);GO:0008080 (10%),DNA binding (10%);ATP binding (10%);N-acetyltransferase activity (10%),,,IPR005172 (46%);IPR028307 (46%);IPR033467 (46%),CRC domain (46%);Lin-54 family (46%);Tesmin/TSO1-like CXC domain (46%)
ATQMVDLCMLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPMHLFDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TATNSSDVELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
STSSFSCLSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (97%);GO:0001533 (49%);GO:0005882 (5%),keratin filament (97%);cornified envelope (49%);intermediate filament (5%),GO:0008092 (49%);GO:0030280 (49%);GO:0005200 (3%),cytoskeletal protein binding (49%);structural constituent of skin epidermis (49%);structural constituent of cytoskeleton (3%),GO:0003334 (49%);GO:0018149 (49%);GO:0031424 (49%),keratinocyte development (49%);peptide cross-linking (49%);keratinization (49%),IPR032444 (100%);IPR039008 (100%);IPR042180 (100%),Keratin type II head (100%);Intermediate filament, rod domain (100%); (100%)
LGEHNLDVLEGN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VATVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (29%),extracellular space (29%),GO:0004252 (100%);GO:0046872 (14%),serine-type endopeptidase activity (100%);metal ion binding (14%),GO:0006508 (29%);GO:0007586 (14%),proteolysis (29%);digestion (14%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
GNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSSSSGYGGGSSR,Euarchontoglires,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Euarchontoglires,,,,,,,,,,,,,,,,,,,,,GO:0005882 (100%);GO:0005615 (6%);GO:0005634 (6%),intermediate filament (100%);extracellular space (6%);nucleus (6%),GO:0005198 (94%);GO:0005200 (6%),structural molecule activity (94%);structural constituent of cytoskeleton (6%),GO:0043588 (78%);GO:0045109 (78%);GO:0007283 (61%),skin development (78%);intermediate filament organization (78%);spermatogenesis (61%),IPR002957 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type I (100%);Intermediate filament, rod domain (100%); (100%)
APVLSDSSCK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (33%),extracellular space (33%),GO:0004252 (100%);GO:0046872 (17%),serine-type endopeptidase activity (100%);metal ion binding (17%),GO:0006508 (33%);GO:0007586 (17%),proteolysis (33%);digestion (17%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
EGNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVNELTEFAK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005615 (88%);GO:0032991 (17%);GO:0005783 (13%),extracellular space (88%);protein-containing complex (17%);endoplasmic reticulum (13%),GO:0046872 (71%);GO:0003677 (17%);GO:0005504 (17%),metal ion binding (71%);DNA binding (17%);fatty acid binding (17%),GO:0009267 (17%);GO:0043066 (17%);GO:0051659 (17%),cellular response to starvation (17%);negative regulation of apoptotic process (17%);maintenance of mitochondrion location (17%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
AEFVEVTK,Bovinae,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Laurasiatheria,Artiodactyla,Ruminantia,Pecora,,Bovidae,Bovinae,,,,,,,,,,,,,,,GO:0005615 (81%);GO:0032991 (25%);GO:0005783 (19%),extracellular space (81%);protein-containing complex (25%);endoplasmic reticulum (19%),GO:0046872 (69%);GO:0003677 (25%);GO:0005504 (25%),metal ion binding (69%);DNA binding (25%);fatty acid binding (25%),GO:0009267 (25%);GO:0043066 (25%);GO:0051659 (25%),cellular response to starvation (25%);negative regulation of apoptotic process (25%);maintenance of mitochondrion location (25%),IPR000264 (100%);IPR014760 (100%);IPR020857 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin, conserved site (100%)
YLYELAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.35 (57%);2.5.1.7 (14%);2.7.13.3 (14%),Pyridoxal kinase (57%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (14%);Histidine kinase (14%),GO:0005615 (86%);GO:0005737 (19%);GO:0032991 (9%),extracellular space (86%);cytoplasm (19%);protein-containing complex (9%),GO:0046872 (43%);GO:0005504 (14%);GO:0003677 (9%),metal ion binding (43%);fatty acid binding (14%);DNA binding (9%),GO:0001542 (13%);GO:0042448 (13%);GO:0060395 (13%),ovulation from ovarian follicle (13%);progesterone metabolic process (13%);SMAD protein signal transduction (13%),IPR000264 (90%);IPR014760 (90%);IPR020858 (90%),ALB/AFP/VDB (90%);Serum albumin, N-terminal (90%);Serum albumin-like (90%)
LLTHPNFN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVTLVSPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (100%),membrane (100%),GO:0008137 (100%);GO:0051539 (100%),NADH dehydrogenase (ubiquinone) activity (100%);4 iron, 4 sulfur cluster binding (100%),GO:0042773 (100%),ATP synthesis coupled electron transport (100%),IPR000283 (100%);IPR001041 (100%);IPR006656 (100%),NADH:ubiquinone oxidoreductase, 75kDa subunit, conserved site (100%);2Fe-2S ferredoxin-type iron-sulfur binding domain (100%);Molybdopterin oxidoreductase (100%)
EYEATLEECAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLHGPPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLSLSVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.5.5.1 (50%);3.5.99.2 (50%),Electron-transferring-flavoprotein dehydrogenase (50%);Aminopyrimidine aminohydrolase (50%),GO:0045095 (92%);GO:0005886 (47%);GO:0001533 (37%),keratin filament (92%);plasma membrane (47%);cornified envelope (37%),GO:0030280 (37%);GO:0046982 (36%);GO:0030246 (35%),structural constituent of skin epidermis (37%);protein heterodimerization activity (36%);carbohydrate binding (35%),GO:0018149 (37%);GO:0051290 (36%);GO:0001867 (35%),peptide cross-linking (37%);protein heterotetramerization (36%);complement activation, lectin pathway (35%),IPR032444 (92%);IPR003054 (91%);IPR039008 (91%),Keratin type II head (92%);Keratin, type II (91%);Intermediate filament, rod domain (91%)
EQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSVHPHGK,Pseudocercospora eumusae,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Dothideomycetes,Dothideomycetidae,,Mycosphaerellales,,,,Mycosphaerellaceae,,,,Pseudocercospora,,,,Pseudocercospora eumusae,,,,,,,,,,,,,,,
SCLLSGWGNTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EQAGGDATENFEDVGHSTDAR,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (80%);GO:0005783 (26%);GO:0005829 (17%),integral component of membrane (80%);endoplasmic reticulum (26%);cytosol (17%),GO:0020037 (82%);GO:0046872 (82%);GO:0019899 (17%),heme binding (82%);metal ion binding (82%);enzyme binding (17%),GO:0046686 (2%);GO:0006631 (0%);GO:0019852 (0%),response to cadmium ion (2%);fatty acid metabolic process (0%);L-ascorbic acid metabolic process (0%),IPR001199 (100%);IPR036400 (100%);IPR018506 (81%),Cytochrome b5-like heme/steroid binding domain (100%);Cytochrome b5-like heme/steroid binding domain superfamily (100%);Cytochrome b5, heme-binding site (81%)
ATEEQLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (36%);3.4.23.- (14%);1.4.1.13 (7%),Peptidylprolyl isomerase (36%);Aspartic endopeptidases (14%);Glutamate synthase (NADPH) (7%),GO:0016021 (40%);GO:0005737 (35%);GO:0005730 (11%),integral component of membrane (40%);cytoplasm (35%);nucleolus (11%),GO:0046872 (42%);GO:0051536 (36%);GO:0043022 (11%),metal ion binding (42%);iron-sulfur cluster binding (36%);ribosome binding (11%),GO:0000054 (11%);GO:0006364 (11%);GO:0006450 (11%),ribosomal subunit export from nucleus (11%);rRNA processing (11%);regulation of translational fidelity (11%),IPR036869 (32%);IPR001623 (32%);IPR017896 (32%),Chaperone J-domain superfamily (32%);DnaJ domain (32%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (32%)
WSLSGDNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLHPLQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005739 (38%);GO:0016021 (38%);GO:0005758 (13%),mitochondrion (38%);integral component of membrane (38%);mitochondrial intermembrane space (13%),GO:0034257 (13%),nicotinamide riboside transmembrane transporter activity (13%),GO:0034553 (50%);GO:0006105 (13%);GO:0007049 (13%),mitochondrial respiratory chain complex II assembly (50%);succinate metabolic process (13%);cell cycle (13%),IPR008381 (44%);IPR000914 (22%);IPR030678 (22%),Succinate dehydrogenase assembly factor 3, mitochondrial (44%);Solute-binding protein family 5 domain (22%);Peptide/nickel binding protein, MppA-type (22%)
NLFAPNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.6.2.1 (60%);1.1.1.22 (40%),P-type phospholipid transporter (60%);UDP-glucose 6-dehydrogenase (40%),GO:0016021 (60%),integral component of membrane (60%),GO:0000287 (60%);GO:0005524 (60%);GO:0140326 (60%),magnesium ion binding (60%);ATP binding (60%);ATPase-coupled intramembrane lipid transporter activity (60%),GO:0015914 (60%);GO:0000271 (40%);GO:0006065 (40%),phospholipid transport (60%);polysaccharide biosynthetic process (40%);UDP-glucuronate biosynthetic process (40%),IPR001757 (60%);IPR006539 (60%);IPR008250 (60%),P-type ATPase (60%);P-type ATPase, subfamily IV (60%);P-type ATPase, A domain superfamily (60%)
LGEHNLDVLE,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVLHEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.104 (74%);3.6.4.12 (4%);6.1.1.3 (3%),Cyanase (74%);DNA helicase (4%);Threonine--tRNA ligase (3%),GO:0016021 (13%);GO:0005737 (7%);GO:0005815 (4%),integral component of membrane (13%);cytoplasm (7%);microtubule organizing center (4%),GO:0003677 (51%);GO:0008824 (48%);GO:0005524 (11%),DNA binding (51%);cyanate hydratase activity (48%);ATP binding (11%),GO:0009439 (48%);GO:0007165 (4%);GO:0006355 (3%),cyanate metabolic process (48%);signal transduction (4%);regulation of transcription, DNA-templated (3%),IPR003712 (44%);IPR036581 (44%);IPR008076 (43%),Cyanate lyase, C-terminal (44%);Cyanate lyase, C-terminal domain superfamily (44%);Cyanate hydratase (43%)
HLVDEPQNLLK,Pecora,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Laurasiatheria,Artiodactyla,Ruminantia,Pecora,,,,,,,,,,,,,,,,,,GO:0005615 (78%);GO:0032991 (26%);GO:0005783 (22%),extracellular space (78%);protein-containing complex (26%);endoplasmic reticulum (22%),GO:0046872 (78%);GO:1903981 (30%);GO:0003677 (26%),metal ion binding (78%);enterobactin binding (30%);DNA binding (26%),GO:0009267 (26%);GO:0043066 (26%);GO:0051659 (26%),cellular response to starvation (26%);negative regulation of apoptotic process (26%);maintenance of mitochondrion location (26%),IPR020858 (100%);IPR000264 (96%);IPR014760 (96%),Serum albumin-like (100%);ALB/AFP/VDB (96%);Serum albumin, N-terminal (96%)
LLVLSEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (21%);2.3.1.269 (16%);1.2.1.59 (11%),Oxidoreductases (21%);Apolipoprotein N-acyltransferase (16%);Glyceraldehyde-3-phosphate dehydrogenase (NAD(P)(+)) (phosphorylating) (11%),GO:0071339 (24%);GO:0005737 (13%);GO:0016021 (12%),MLL1 complex (24%);cytoplasm (13%);integral component of membrane (12%),GO:0046872 (28%);GO:0060090 (10%);GO:0003735 (7%),metal ion binding (28%);molecular adaptor activity (10%);structural constituent of ribosome (7%),GO:0007165 (11%);GO:0006412 (7%);GO:0006355 (5%),signal transduction (11%);translation (7%);regulation of transcription, DNA-templated (5%),IPR022255 (21%);IPR037915 (21%);IPR043449 (21%),Domain of unknown function DUF3776 (21%);PHD finger protein 20 (21%);PHD finger protein 20-like (21%)
VLLPYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (28%);2.1.1.72 (11%);2.7.8.13 (11%),DNA-directed DNA polymerase (28%);Site-specific DNA-methyltransferase (adenine-specific) (11%);Phospho-N-acetylmuramoyl-pentapeptide-transferase (11%),GO:0016021 (54%);GO:0005886 (36%);GO:0005737 (11%),integral component of membrane (54%);plasma membrane (36%);cytoplasm (11%),GO:0005524 (11%);GO:0046872 (10%);GO:0003887 (7%),ATP binding (11%);metal ion binding (10%);DNA-directed DNA polymerase activity (7%),GO:0030420 (31%);GO:0006281 (12%);GO:0006261 (6%),establishment of competence for transformation (31%);DNA repair (12%);DNA-dependent DNA replication (6%),IPR001279 (28%);IPR035681 (28%);IPR036866 (28%),Metallo-beta-lactamase (28%);ComA-like, MBL domain (28%);Ribonuclease Z/Hydroxyacylglutathione hydrolase-like (28%)
QFQLHPLQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSPATLNSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ECLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.93 (24%);2.7.13.3 (4%);1.1.1.100 (3%),Proprotein convertase 1 (24%);Histidine kinase (4%);3-oxoacyl-[acyl-carrier-protein] reductase (3%),GO:0005634 (13%);GO:0016021 (11%);GO:0005737 (4%),nucleus (13%);integral component of membrane (11%);cytoplasm (4%),GO:0046872 (18%);GO:0005524 (11%);GO:0016740 (8%),metal ion binding (18%);ATP binding (11%);transferase activity (8%),GO:0006355 (6%);GO:0009396 (4%);GO:0030177 (4%),regulation of transcription, DNA-templated (6%);folic acid-containing compound biosynthetic process (4%);positive regulation of Wnt signaling pathway (4%),IPR027417 (8%);IPR013083 (7%);IPR026607 (7%),P-loop containing nucleoside triphosphate hydrolase (8%);Zinc finger, RING/FYVE/PHD-type (7%);DMRT/protein doublesex/protein male abnormal 3 (7%)
HSYLHSHPQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLEHPFLLK,Parasitella parasitica,Eukaryota,Fungi,,,Mucoromycota,Mucoromycotina,,Mucoromycetes,,,Mucorales,Mucorineae,,,Mucoraceae,,,,Parasitella,,,,Parasitella parasitica,,,,,,,,,,GO:0004672 (100%);GO:0005524 (100%),protein kinase activity (100%);ATP binding (100%),,,IPR000719 (100%);IPR008271 (100%);IPR011009 (100%),Protein kinase domain (100%);Serine/threonine-protein kinase, active site (100%);Protein kinase-like domain superfamily (100%)
LGEHNLD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLGHVPR,Metazoa,Eukaryota,Metazoa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR000326 (50%);IPR000477 (50%);IPR013783 (50%),Phosphatidic acid phosphatase type 2/haloperoxidase (50%);Reverse transcriptase domain (50%);Immunoglobulin-like fold (50%)
VATVSANWDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TYDLVLSAPTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLQVVVLGHQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPVNGMPSAAMPLTVGMMLSLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTLLYPK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.3.16 (100%),Protein-serine/threonine phosphatase (100%),GO:0005634 (72%);GO:0016021 (11%),nucleus (72%);integral component of membrane (11%),GO:0106306 (56%);GO:0106307 (56%);GO:0004721 (22%),protein serine phosphatase activity (56%);protein threonine phosphatase activity (56%);phosphoprotein phosphatase activity (22%),GO:0006749 (6%),glutathione metabolic process (6%),IPR004274 (78%);IPR023214 (78%);IPR029071 (78%),FCP1 homology domain (78%);HAD superfamily (78%);Ubiquitin-like domain superfamily (78%)
GLGLTAHLTTGQAG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVLDLSGFK,Delftia,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,Burkholderiales,,,,Comamonadaceae,,,,Delftia,,,,,,,,,,,,,,GO:0030246 (100%);GO:0004180 (33%),carbohydrate binding (100%);carboxypeptidase activity (33%),,,IPR011050 (100%);IPR013783 (100%);IPR013784 (100%),Pectin lyase fold/virulence factor (100%);Immunoglobulin-like fold (100%);Carbohydrate-binding-like fold (100%)
VVHVAFK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0042597 (50%),periplasmic space (50%),GO:0016787 (50%),hydrolase activity (50%),GO:0006935 (50%),chemotaxis (50%),IPR005064 (50%);IPR007597 (50%);IPR028976 (50%),Bordetella uptake gene (50%);CheC-like protein (50%);CheC-like superfamily (50%)
MTNASQK,Acinetobacter bereziniae,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,Pseudomonadales,,,,Moraxellaceae,,,,Acinetobacter,,,,Acinetobacter bereziniae,,,,,,1.-.-.- (100%),Oxidoreductases (100%),GO:0016021 (25%),integral component of membrane (25%),GO:0004497 (75%);GO:0016705 (75%);GO:0003677 (25%),monooxygenase activity (75%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (75%);DNA binding (25%),,,IPR011251 (75%);IPR016215 (75%);IPR036661 (75%),Luciferase-like domain (75%);Nitrilotriacetate monooxygenase component A/pristinamycin IIA synthase subunit A (75%);Luciferase-like domain superfamily (75%)
AHLLAAFK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (100%),catalytic activity (100%),,,IPR003115 (57%);IPR036086 (57%);IPR001509 (43%),ParB/Sulfiredoxin (57%);ParB/Sulfiredoxin superfamily (57%);NAD-dependent epimerase/dehydratase (43%)
NGGMTQK,Enterococcus,Bacteria,,,,Firmicutes,,,Bacilli,,,Lactobacillales,,,,Enterococcaceae,,,,Enterococcus,,,,,,,,,,,,,,,,,,,
TFFGDYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6.5.- (50%);2.5.1.25 (50%),With a quinone or similar compound as acceptor (50%);tRNA-uridine aminocarboxypropyltransferase (50%),GO:0016021 (20%),integral component of membrane (20%),GO:0004181 (20%);GO:0008137 (20%);GO:0008168 (20%),metallocarboxypeptidase activity (20%);NADH dehydrogenase (ubiquinone) activity (20%);methyltransferase activity (20%),GO:0008033 (20%);GO:0032259 (20%);GO:0042773 (20%),tRNA processing (20%);methylation (20%);ATP synthesis coupled electron transport (20%),IPR009045 (33%);IPR024019 (33%);IPR000834 (17%),Hedgehog signalling/DD-peptidase zinc-binding domain superfamily (33%);Conserved hypothetical protein CHP04096 (33%);Peptidase M14, carboxypeptidase A (17%)
GELPPLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MTVWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.26 (14%);1.1.5.3 (8%);2.1.1.63 (8%),Adenosylcobinamide-GDP ribazoletransferase (14%);Glycerol-3-phosphate dehydrogenase (8%);Methylated-DNA--[protein]-cysteine S-methyltransferase (8%),GO:0016021 (55%);GO:0005886 (36%);GO:0005737 (9%),integral component of membrane (55%);plasma membrane (36%);cytoplasm (9%),GO:0008270 (9%);GO:0016740 (3%);GO:0004568 (3%),zinc ion binding (9%);transferase activity (3%);chitinase activity (3%),GO:0006032 (3%);GO:0016998 (3%);GO:0007165 (2%),chitin catabolic process (3%);cell wall macromolecule catabolic process (3%);signal transduction (2%),IPR003838 (28%);IPR025857 (28%);IPR000620 (7%),ABC3 transporter permease protein domain (28%);MacB-like periplasmic core domain (28%);EamA domain (7%)
DLLLLTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.24 (100%),Glucose-1-phosphate thymidylyltransferase (100%),GO:0016021 (73%);GO:0005886 (57%);GO:0005871 (3%),integral component of membrane (73%);plasma membrane (57%);kinesin complex (3%),GO:0019825 (30%);GO:0020037 (30%);GO:0005524 (10%),oxygen binding (30%);heme binding (30%);ATP binding (10%),GO:0055085 (17%);GO:0000160 (7%);GO:0006355 (7%),transmembrane transport (17%);phosphorelay signal transduction system (7%);regulation of transcription, DNA-templated (7%),IPR012292 (27%);IPR020948 (27%);IPR000515 (15%),Globin/Protoglobin (27%);Phosphate-starvation-induced PsiE-like (27%);ABC transporter type 1, transmembrane domain MetI-like (15%)
FVAGTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.1 (21%);1.5.5.2 (16%);1.8.1.4 (11%),Carbonic anhydrase (21%);Proline dehydrogenase (16%);Dihydrolipoyl dehydrogenase (11%),GO:0016021 (42%);GO:0005886 (6%);GO:0005743 (4%),integral component of membrane (42%);plasma membrane (6%);mitochondrial inner membrane (4%),GO:0005524 (11%);GO:0003824 (6%);GO:0008270 (6%),ATP binding (11%);catalytic activity (6%);zinc ion binding (6%),GO:0015976 (4%);GO:0006811 (3%);GO:0006979 (3%),carbon utilization (4%);ion transport (3%);response to oxidative stress (3%),IPR003399 (29%);IPR005693 (29%);IPR024516 (20%),Mce/MlaD (29%);Virulence factor Mce protein (29%);Mammalian cell entry, C-terminal (20%)
RPPHR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.2 (6%);2.3.2.27 (5%);2.7.13.3 (3%),Glutamate--cysteine ligase (6%);RING-type E3 ubiquitin transferase (5%);Histidine kinase (3%),GO:0016021 (33%);GO:0005737 (5%);GO:0005886 (5%),integral component of membrane (33%);cytoplasm (5%);plasma membrane (5%),GO:0005524 (16%);GO:0046872 (8%);GO:0003677 (8%),ATP binding (16%);metal ion binding (8%);DNA binding (8%),GO:0032259 (3%);GO:0006637 (1%);GO:0005975 (1%),methylation (3%);acyl-CoA metabolic process (1%);carbohydrate metabolic process (1%),IPR027417 (12%);IPR003347 (6%);IPR003593 (5%),P-loop containing nucleoside triphosphate hydrolase (12%);JmjC domain (6%);AAA+ ATPase domain (5%)
GYPVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (12%);3.6.4.- (7%);4.3.1.19 (7%),Acting on ester bonds (12%);Acting on ATP; involved in cellular and subcellular movement (7%);Threonine ammonia-lyase (7%),GO:0016021 (18%);GO:0005737 (9%);GO:0005886 (6%),integral component of membrane (18%);cytoplasm (9%);plasma membrane (6%),GO:0003677 (17%);GO:0005524 (11%);GO:0046872 (9%),DNA binding (17%);ATP binding (11%);metal ion binding (9%),GO:0000160 (6%);GO:0006355 (6%);GO:0005975 (5%),phosphorelay signal transduction system (6%);regulation of transcription, DNA-templated (6%);carbohydrate metabolic process (5%),IPR012486 (8%);IPR040185 (8%);IPR021819 (8%),Far11/STRP, N-terminal (8%);Far11/STRP (8%);Far11/STRP, C-terminal (8%)
LPTVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.54 (8%);2.7.7.48 (6%);1.7.1.4 (5%),3-deoxy-7-phosphoheptulonate synthase (8%);RNA-directed RNA polymerase (6%);Nitrite reductase (NAD(P)H) (5%),GO:0016021 (24%);GO:0005886 (5%);GO:0005737 (4%),integral component of membrane (24%);plasma membrane (5%);cytoplasm (4%),GO:0046872 (14%);GO:0051539 (10%);GO:0003677 (10%),metal ion binding (14%);4 iron, 4 sulfur cluster binding (10%);DNA binding (10%),GO:0042128 (7%);GO:0006355 (2%);GO:0005975 (2%),nitrate assimilation (7%);regulation of transcription, DNA-templated (2%);carbohydrate metabolic process (2%),IPR036465 (8%);IPR002035 (8%);IPR027417 (7%),von Willebrand factor A-like domain superfamily (8%);von Willebrand factor, type A (8%);P-loop containing nucleoside triphosphate hydrolase (7%)
LYADGGHVFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.11 (97%);2.3.1.20 (1%);2.3.3.14 (1%),3-methyl-2-oxobutanoate hydroxymethyltransferase (97%);Diacylglycerol O-acyltransferase (1%);Homocitrate synthase (1%),GO:0005737 (74%);GO:0016021 (2%);GO:0005886 (1%),cytoplasm (74%);integral component of membrane (2%);plasma membrane (1%),GO:0046872 (86%);GO:0003864 (74%);GO:0008168 (72%),metal ion binding (86%);3-methyl-2-oxobutanoate hydroxymethyltransferase activity (74%);methyltransferase activity (72%),GO:0015940 (74%);GO:0032259 (72%);GO:0045892 (4%),pantothenate biosynthetic process (74%);methylation (72%);negative regulation of transcription, DNA-templated (4%),IPR003700 (73%);IPR015813 (73%);IPR040442 (73%),Ketopantoate hydroxymethyltransferase (73%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (73%);Pyruvate kinase-like domain superfamily (73%)
LPVSTVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.4.1 (33%);3.1.4.46 (33%);6.1.1.20 (33%),Pyruvate dehydrogenase (acetyl-transferring) (33%);Glycerophosphodiester phosphodiesterase (33%);Phenylalanine--tRNA ligase (33%),GO:0005886 (36%);GO:0042597 (36%);GO:0016021 (11%),plasma membrane (36%);periplasmic space (36%);integral component of membrane (11%),GO:0042626 (39%);GO:0004602 (8%);GO:0004673 (6%),ATPase-coupled transmembrane transporter activity (39%);glutathione peroxidase activity (8%);protein histidine kinase activity (6%),GO:0006979 (8%);GO:0009306 (8%);GO:0000160 (6%),response to oxidative stress (8%);protein secretion (8%);phosphorelay signal transduction system (6%),IPR001638 (25%);IPR010067 (25%);IPR015168 (25%),Solute-binding protein  family 3/N-terminal domain of MltF (25%);Aliphatic sulfonates-binding protein (25%);SsuA/THI5-like (25%)
LSGVSSNAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QNRPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.1 (65%);3.5.2.9 (6%);2.4.1.12 (6%),Receptor protein-tyrosine kinase (65%);5-oxoprolinase (ATP-hydrolyzing) (6%);Cellulose synthase (UDP-forming) (6%),GO:0016021 (28%);GO:0005783 (17%);GO:0005634 (6%),integral component of membrane (28%);endoplasmic reticulum (17%);nucleus (6%),GO:0005524 (19%);GO:0004714 (14%);GO:0030246 (9%),ATP binding (19%);transmembrane receptor protein tyrosine kinase activity (14%);carbohydrate binding (9%),GO:0007169 (13%);GO:0015074 (5%);GO:0007264 (4%),transmembrane receptor protein tyrosine kinase signaling pathway (13%);DNA integration (5%);small GTPase mediated signal transduction (4%),IPR009011 (18%);IPR012913 (18%);IPR011009 (14%),Mannose-6-phosphate receptor binding domain superfamily (18%);Protein OS9-like (18%);Protein kinase-like domain superfamily (14%)
EYGGMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.6.5.- (75%);1.6.5.3 (25%);1.6.99.5 (25%),With a quinone or similar compound as acceptor (75%);Transferred entry: 7.1.1.2 (25%);Transferred entry: 1.6.5.11 (25%),GO:0016021 (41%),integral component of membrane (41%),GO:0003677 (46%);GO:0004803 (43%);GO:0008137 (37%),DNA binding (46%);transposase activity (43%);NADH dehydrogenase (ubiquinone) activity (37%),GO:0006313 (43%);GO:0042773 (37%);GO:0015074 (4%),transposition, DNA-mediated (43%);ATP synthesis coupled electron transport (37%);DNA integration (4%),IPR002514 (43%);IPR009057 (43%);IPR001750 (36%),Transposase IS3/IS911family (43%);Homeobox-like domain superfamily (43%);NADH:quinone oxidoreductase/Mrp antiporter, membrane subunit (36%)
LGNLFVVLK,Odobenus rosmarus divergens,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,Laurasiatheria,Carnivora,Caniformia,,,Odobenidae,,,,Odobenus,,,,Odobenus rosmarus,Odobenus rosmarus divergens,,,,,,,GO:0005852 (100%);GO:0016282 (100%);GO:0033290 (100%),eukaryotic translation initiation factor 3 complex (100%);eukaryotic 43S preinitiation complex (100%);eukaryotic 48S preinitiation complex (100%),GO:0003743 (100%),translation initiation factor activity (100%),GO:0001732 (100%),formation of cytoplasmic translation initiation complex (100%),IPR000717 (100%);IPR027512 (100%),Proteasome component (PCI) domain (100%);Eukaryotic translation initiation factor 3 subunit A (100%)
VEGLLTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (43%);1.8.1.2 (33%);4.2.1.22 (10%),DNA helicase (43%);Assimilatory sulfite reductase (NADPH) (33%);Cystathionine beta-synthase (10%),GO:0005634 (18%);GO:0042555 (18%);GO:0009337 (14%),nucleus (18%);MCM complex (18%);sulfite reductase complex (NADPH) (14%),GO:0005524 (40%);GO:0003678 (18%);GO:0004783 (14%),ATP binding (40%);DNA helicase activity (18%);sulfite reductase (NADPH) activity (14%),GO:0000103 (14%);GO:0019344 (14%);GO:0070814 (14%),sulfate assimilation (14%);cysteine biosynthetic process (14%);hydrogen sulfide biosynthetic process (14%),IPR027417 (19%);IPR012340 (14%);IPR031327 (14%),P-loop containing nucleoside triphosphate hydrolase (19%);Nucleic acid-binding, OB-fold (14%);Mini-chromosome maintenance protein (14%)
LAAFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.47 (15%);1.21.98.4 (5%);2.4.1.12 (5%),8-amino-7-oxononanoate synthase (15%);PqqA peptide cyclase (5%);Cellulose synthase (UDP-forming) (5%),GO:0016021 (16%);GO:0005737 (5%);GO:0005634 (5%),integral component of membrane (16%);cytoplasm (5%);nucleus (5%),GO:0005524 (13%);GO:0016874 (10%);GO:0030170 (7%),ATP binding (13%);ligase activity (10%);pyridoxal phosphate binding (7%),GO:0009058 (4%);GO:0009102 (3%);GO:0051301 (3%),biosynthetic process (4%);biotin biosynthetic process (3%);cell division (3%),IPR025110 (15%);IPR000873 (15%);IPR042099 (12%),AMP-binding enzyme, C-terminal domain (15%);AMP-dependent synthetase/ligase (15%);ANL, N-terminal domain (12%)
GLVPFELYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GVPFSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.16.4 (85%);2.1.1.72 (10%);3.1.-.- (2%),Serine-type D-Ala-D-Ala carboxypeptidase (85%);Site-specific DNA-methyltransferase (adenine-specific) (10%);Acting on ester bonds (2%),GO:0005887 (25%);GO:0016021 (22%);GO:0035658 (22%),integral component of plasma membrane (25%);integral component of membrane (22%);Mon1-Ccz1 complex (22%),GO:0008658 (25%);GO:0008955 (25%);GO:0009002 (25%),penicillin binding (25%);peptidoglycan glycosyltransferase activity (25%);serine-type D-Ala-D-Ala carboxypeptidase activity (25%),GO:0000917 (25%);GO:0008360 (25%);GO:0009252 (25%),division septum assembly (25%);regulation of cell shape (25%);peptidoglycan biosynthetic process (25%),IPR001460 (27%);IPR005311 (27%);IPR012338 (27%),Penicillin-binding protein, transpeptidase (27%);Penicillin-binding protein, dimerisation domain (27%);Beta-lactamase/transpeptidase-like (27%)
MLVDLGALYQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HVVGQAK,Oxalobacteraceae,Bacteria,,,,Proteobacteria,,,Betaproteobacteria,,,Burkholderiales,,,,Oxalobacteraceae,,,,,,,,,,,,,,,,GO:0009376 (100%),HslUV protease complex (100%),GO:0005524 (100%);GO:0008233 (100%);GO:0016887 (100%),ATP binding (100%);peptidase activity (100%);ATPase (100%),GO:0043335 (100%),protein unfolding (100%),IPR003593 (100%);IPR003959 (100%);IPR004491 (100%),AAA+ ATPase domain (100%);ATPase, AAA-type, core (100%);Heat shock protein HslU (100%)
SSPAQVDTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTLHATK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (22%),integral component of membrane (22%),GO:0005524 (33%);GO:0008017 (33%);GO:1990939 (33%),ATP binding (33%);microtubule binding (33%);ATP-dependent microtubule motor activity (33%),GO:0007018 (33%);GO:0001522 (11%),microtubule-based movement (33%);pseudouridine synthesis (11%),IPR000008 (24%);IPR035892 (24%);IPR037768 (24%),C2 domain (24%);C2 domain superfamily (24%);Copine, C2B domain (24%)
NHLQLFSK,Crenarchaeota archaeon,Archaea,,,,Crenarchaeota,,,,,,,,,,,,,,,,,,Crenarchaeota archaeon,,,,,,,,,,,,,,,
AELVATLER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008410 (67%);GO:0004315 (33%),CoA-transferase activity (67%);3-oxoacyl-[acyl-carrier-protein] synthase activity (33%),GO:0006633 (33%),fatty acid biosynthetic process (33%),IPR003673 (67%);IPR023606 (67%);IPR009081 (33%),CoA-transferase family III (67%);CoA-transferase family III domain 1 superfamily (67%);Phosphopantetheine binding ACP domain (33%)
LSVWLVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLATLALYTDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DSGTGFPEALLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFEPYVTTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (100%),Histidine kinase (100%),GO:0016021 (96%),integral component of membrane (96%),GO:0000155 (97%);GO:0016301 (2%);GO:0004673 (1%),phosphorelay sensor kinase activity (97%);kinase activity (2%);protein histidine kinase activity (1%),GO:0006355 (3%);GO:0016310 (0%),regulation of transcription, DNA-templated (3%);phosphorylation (0%),IPR003594 (100%);IPR004358 (100%);IPR036890 (100%),Histidine kinase/HSP90-like ATPase (100%);Signal transduction histidine kinase-related protein, C-terminal (100%);Histidine kinase/HSP90-like ATPase superfamily (100%)
LPGNLLVVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GSHGSQVLFASTVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLFPVLAR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%);GO:0005886 (86%),integral component of membrane (100%);plasma membrane (86%),,,,,IPR029303 (86%);IPR041229 (14%),Polysaccharide biosynthesis protein, C-terminal domain (86%);Apea-like HEPN (14%)
AHAEALGLTTGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QLLVNHGK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.3.4 (100%),3-dehydroquinate synthase (100%),GO:0005737 (100%);GO:0016021 (100%),cytoplasm (100%);integral component of membrane (100%),GO:0000166 (100%);GO:0003856 (100%);GO:0046872 (100%),nucleotide binding (100%);3-dehydroquinate synthase activity (100%);metal ion binding (100%),GO:0009073 (100%);GO:0009423 (100%),aromatic amino acid family biosynthetic process (100%);chorismate biosynthetic process (100%),IPR036527 (94%);IPR016037 (6%);IPR030960 (6%),SCP2 sterol-binding domain superfamily (94%);3-dehydroquinate synthase AroB (6%);3-dehydroquinate synthase domain (6%)
TLTTLEALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLVVSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.29 (27%);3.6.4.12 (20%);6.3.3.2 (20%),tRNA-guanine(34) transglycosylase (27%);DNA helicase (20%);5-formyltetrahydrofolate cyclo-ligase (20%),GO:0032039 (15%);GO:0016021 (10%);GO:0005634 (8%),integrator complex (15%);integral component of membrane (10%);nucleus (8%),GO:0005524 (24%);GO:0003700 (8%);GO:0043531 (8%),ATP binding (24%);DNA-binding transcription factor activity (8%);ADP binding (8%),GO:0016180 (15%);GO:0006281 (12%);GO:0006310 (12%),snRNA processing (15%);DNA repair (12%);DNA recombination (12%),IPR007372 (42%);IPR036761 (42%);IPR027417 (13%),Lipid/polyisoprenoid-binding, YceI-like (42%);Lipid/polyisoprenoid-binding, YceI-like superfamily (42%);P-loop containing nucleoside triphosphate hydrolase (13%)
NPEVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.21 (17%);2.3.1.37 (12%);3.2.1.22 (11%),Squalene synthase (17%);5-aminolevulinate synthase (12%);Alpha-galactosidase (11%),GO:0016020 (19%);GO:0016021 (19%);GO:0042597 (18%),membrane (19%);integral component of membrane (19%);periplasmic space (18%),GO:0042626 (18%);GO:0005524 (11%);GO:0005506 (7%),ATPase-coupled transmembrane transporter activity (18%);ATP binding (11%);iron ion binding (7%),GO:0005975 (8%);GO:0008610 (3%);GO:0055085 (3%),carbohydrate metabolic process (8%);lipid biosynthetic process (3%);transmembrane transport (3%),IPR001638 (16%);IPR015168 (16%);IPR010067 (16%),Solute-binding protein  family 3/N-terminal domain of MltF (16%);SsuA/THI5-like (16%);Aliphatic sulfonates-binding protein (16%)